Primary cutaneous anaplastic large-cell lymphoma: Complete remission for 13 years after denileukin diftitox

Daniel J Lewis; Harry Dao Jr; Priyadharsini Nagarajan; Madeleine Duvic

doi:10.1016/j.jdcr.2017.06.031

Primary cutaneous anaplastic large-cell lymphoma: Complete remission for 13 years after denileukin diftitox

JAAD Case Rep. 2017 Oct 25;3(6):501-504. doi: 10.1016/j.jdcr.2017.06.031. eCollection 2017 Nov.

Authors

Daniel J Lewis^{1

2}, Harry Dao Jr³, Priyadharsini Nagarajan⁴, Madeleine Duvic²

Affiliations

¹ School of Medicine, Baylor College of Medicine, Houston, Texas.
² Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
³ Department of Dermatology, Baylor College of Medicine, Houston, Texas.
⁴ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

No abstract available

Keywords: CD25; CLS, capillary leak syndrome; CR, complete remission; CTCL, cutaneous T-cell lymphoma; DD, denileukin diftitox; E7777; Treg, T-regulatory cell; complete remission; denileukin diftitox; pcALCL, primary cutaneous anaplastic large-cell lymphoma; primary cutaneous anaplastic large-cell lymphoma.

Publication types

Case Reports